• 中国科技核心期刊
  • 中国科技论文统计源期刊
  • 安徽省优秀科技期刊
  • 中国高校优秀期刊

视黄醇结合蛋白4和脂蛋白相关磷脂酶A2水平与冠心病及冠状动脉病变特征的相关性分析

葛玲, 程训民, 杨松, 唐杨章, 谢义民

葛玲, 程训民, 杨松, 唐杨章, 谢义民. 视黄醇结合蛋白4和脂蛋白相关磷脂酶A2水平与冠心病及冠状动脉病变特征的相关性分析[J]. 蚌埠医科大学学报, 2015, 40(8): 1102-1104. DOI: 10.13898/j.cnki.issn.1000-2200.2015.08.039
引用本文: 葛玲, 程训民, 杨松, 唐杨章, 谢义民. 视黄醇结合蛋白4和脂蛋白相关磷脂酶A2水平与冠心病及冠状动脉病变特征的相关性分析[J]. 蚌埠医科大学学报, 2015, 40(8): 1102-1104. DOI: 10.13898/j.cnki.issn.1000-2200.2015.08.039
GE Ling, CHENG Xun-min, YANG Song, TANG Yang-zhang, XIE Yi-min. The relationships between the levels of retinol binding protein 4 and lipoprotein associated phospholipase A2,and coronary heart disease and coronary artery lesion characteristics[J]. Journal of Bengbu Medical University, 2015, 40(8): 1102-1104. DOI: 10.13898/j.cnki.issn.1000-2200.2015.08.039
Citation: GE Ling, CHENG Xun-min, YANG Song, TANG Yang-zhang, XIE Yi-min. The relationships between the levels of retinol binding protein 4 and lipoprotein associated phospholipase A2,and coronary heart disease and coronary artery lesion characteristics[J]. Journal of Bengbu Medical University, 2015, 40(8): 1102-1104. DOI: 10.13898/j.cnki.issn.1000-2200.2015.08.039

视黄醇结合蛋白4和脂蛋白相关磷脂酶A2水平与冠心病及冠状动脉病变特征的相关性分析

基金项目: 

安徽省淮北市科技局资助项目(20120314)

详细信息
    作者简介:

    葛玲(1972-),女,主管检验师.

  • 中图分类号: R543.3

The relationships between the levels of retinol binding protein 4 and lipoprotein associated phospholipase A2,and coronary heart disease and coronary artery lesion characteristics

  • 摘要: 目的:探讨血清视黄醇结合蛋白4(RBP4)、脂蛋白相关磷脂酶A2(Lp-PLA2)水平与冠心病的稳定性、恶化及选择性冠状动脉(冠脉)造影结果的关系。方法:将89例冠心病患者根据冠脉造影结果分为4组,造影结果正常者14例为对照组,异常者根据冠脉病变支数,分为单支病变组22例,2支病变组21例和3支病变组32例。于造影前采集血标本,酶联免疫吸附法分别定量测定4组患者Lp-PLA2、RBP4 水平。结果:3支病变组患者血清RBP4和Lp-PLA2 水平均明显高于对照组、单支和2支病变组(P<0.01),而2支病变组患者血清Lp-PLA2水平亦均显著高于对照组和单支病变组(P<0.01) ;单支病变与对照组Lp-PLA2 水平差异无统计学意义(P>0.05),单支和2支病变组及对照组血清RBP4水平差异均无统计学意义(P>0.05)。结论:冠心病患者血清Lp-PLA2、RBP4 水平与冠脉病变支数有关,可以在一定程度上反映冠脉的狭窄程度。
    Abstract: Objective:To investigate the relationships between the levels of retinol binding protein 4(RBP4) and lipoprotein associated phospholipase A2(Lp-PLA2),and stability of deterioration of coronary heart disease and selective coronary angiography results.Methods:Eighty-nine patients with coronary heart disease were divided into the control group(without vessel lesion),1 vessel lesion group,2 branches lesion group and 3 branches lesion group according to the results of coronary angiography.The levels of Lp-PLA2 and RBP4 in 4 groups before angiography were detected by enzyme-linked immunosorbent assay.Results:The levels of Lp-PLA2 and RBP4 in 3 branches lesion group were significantly higher than those in control group,1 vessel lesion group and 2 branches lesion group(P<0.01).The level of Lp-PLA2 in 2 branches lesion group was significantly higher than those in control group and 1 vessel lesion group(P<0.01).The difference of the Lp-PLA2 levels between 1 branch lesion group and control group was not statistically significant(P>0.05).The difference of the RBP4 levels between 1 branch lesion group,2 branches lesion group 2 and control group were not statistically significant(P>0.05).Conclusions:The levels of serum Lp-PLA2 and RBP4 in patients with coronary heart disease are related to the number of coronary artery lesion,which can predict the stenosis degree of coronary artery in a certain extent.
  • [1] 陆再英,钟南山.内科学[M].7 版.北京:人民卫生出版社,2008:274.
    [2]

    Khuseyinova N,Koenig W.Predicting the risk of cardiovascular disease:where does lipoprotein-associated phospholipase A(2) fit in?[J].Mol Diagn Ther,2007,11(4):203-217.

    [3]

    Papathanasiou AI,Lourida ES,Tsironis LD,et al.Short-and long-term elevation of autoantibody titers against oxidized LDL in patients with acute corcnay syndromes.Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment[J].Atherosclerosis,2008,196(1):289-297.

    [4]

    Tselepis AF,Rizzo M,Goudevenos IA.Therapeutic modulation of lipoprotein-associated phospholipase A2(Lp-PLA2)[J].Curr Pharm Des,2011,17(33):3656-3661.

    [5]

    Ronti T,Lupattelli G,Mannarino E.The endocrine function of adipose tissue:an update[J].Clin Endocrinol(Oxf),2006,64(4):355-365.

    [6] 刘更夫,左华泽,骆明波,等.血清视黄醇结合蛋白4水平与动脉粥样硬化危险因素的相关性分析[J].微循环学杂志,2009,19(3):61-63.
    [7] 谢玉婷,汪年松.视黄醇结合蛋白4与心血管疾病的研究进展[J/CD].中华临床医师杂志:电子版,2011,5(6):1698-1700.
    [8] 张敏,唐荣珍,曹晓江,等.冠心病合并2型糖尿病血清视黄醇结合蛋白4水平与冠状动脉病变程度的相关性研究[J].华西医学,2011,26(12):1818-1821.
    [9] 周海艳,岳晓丽,石建华.视黄醇结合蛋白4与老年2型糖尿病视网膜病变的相关性研究[J].蚌埠医学院学报,2013,38(7):803-808.
    [10] 洪衡,王明生,王河,等.不同类型急性心肌梗死冠状动脉病变特点的观察[J].中国循环杂志,2007,22(3):187-190.
    [11] 时永辉,牛冬梅,吴嘉,等.冠心病患者血清脂蛋白相关磷脂酶A2与氧化低密度脂蛋白水平[J].临床检验杂志,2013,31(2):92-95.
  • 期刊类型引用(1)

    1. 吕留强, 唐扬章, 王士强, 谢义民, 葛玲, 程训民. 冠心病患者血清视黄醇结合蛋白4、脂蛋白相关磷脂酶A2水平变化及其临床意义. 临床医学. 2019(08): 59-61 . 百度学术

    其他类型引用(2)

计量
  • 文章访问数:  3456
  • HTML全文浏览量:  630
  • PDF下载量:  121
  • 被引次数: 3
出版历程
  • 收稿日期:  2014-07-07

目录

    /

    返回文章
    返回